Mangoceuticals, Inc.(MGRX)

盘后0.52600.00-0.75%19:59 EST

0.5300+0.1739+48.83%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Mangoceuticals, Inc. 宣布与 Cube Group 合作推出高达 1 亿美元的 Solana 专注数字资产国库 (Dat) 战略
  美股速递 · 2025-12-19
  Mangoceuticals, Inc. 宣布与 Cube Group 合作推出高达 1 亿美元的 Solana 专注数字资产国库 (Dat) 战略
- 美股异动 | “合作澄清”一度引发暴跌 Mangoceuticals(MGRX.US)股价坐上过山车
  智通财经 · 2025-11-14
  美股异动 | “合作澄清”一度引发暴跌 Mangoceuticals(MGRX.US)股价坐上过山车
- Mangoceuticals通过Mangorx Direct和Peaches Rx Direct公司现已直接向客户提供礼来和诺和诺德的GLP-1药物
  美股速递 · 2025-11-14
  Mangoceuticals通过Mangorx Direct和Peaches Rx Direct公司现已直接向客户提供礼来和诺和诺德的GLP-1药物
- Mangoceuticals Inc：Mangoceuticals与礼来或诺和诺德没有直接的合同关系
  美股速递 · 2025-11-14
  Mangoceuticals Inc：Mangoceuticals与礼来或诺和诺德没有直接的合同关系
- Novo Nordisk与礼来发言人称两公司与减重平台Mangoceuticals并无关联
  美股速递 · 2025-11-14
  Novo Nordisk与礼来发言人称两公司与减重平台Mangoceuticals并无关联
- Mangoceuticals 股价在盘前上涨 48%，因公司与礼来和诺和诺德合作销售减肥药物
  美股速递 · 2025-11-13
  Mangoceuticals 股价在盘前上涨 48%，因公司与礼来和诺和诺德合作销售减肥药物
- Mangoceuticals与礼来和诺和诺德合作提供负担得起的Zepbound和Wegovy肥胖管理方案
  美股速递 · 2025-11-13
  Mangoceuticals与礼来和诺和诺德合作提供负担得起的Zepbound和Wegovy肥胖管理方案
- Mangoceuticals, Inc.盘中异动急速拉升7.60%报2.34美元
  市场透视 · 2025-10-10
  Mangoceuticals, Inc.盘中异动急速拉升7.60%报2.34美元
- Mangoceuticals, Inc.盘中异动早盘股价大涨5.02%
  市场透视 · 2025-10-03
  Mangoceuticals, Inc.盘中异动早盘股价大涨5.02%
- Mangoceuticals, Inc.盘中异动急速跳水5.29%报2.15美元
  市场透视 · 2025-09-16
  Mangoceuticals, Inc.盘中异动急速跳水5.29%报2.15美元
- Mangoceuticals, Inc.盘中异动早盘股价大跌5.11%
  市场透视 · 2025-03-10
  Mangoceuticals, Inc.盘中异动早盘股价大跌5.11%
- Mangoceuticals, Inc.盘中异动早盘股价大跌6.50%
  市场透视 · 2025-03-05
  Mangoceuticals, Inc.盘中异动早盘股价大跌6.50%
- Mangoceuticals, Inc.盘中异动大幅下跌5.76%
  市场透视 · 2025-03-05
  Mangoceuticals, Inc.盘中异动大幅下跌5.76%
- Mangoceuticals, Inc.盘中异动股价大跌5.34%报3.91美元
  市场透视 · 2025-03-03
  Mangoceuticals, Inc.盘中异动股价大跌5.34%报3.91美元
- Mangoceuticals, Inc.盘中异动股价大跌5.53%报3.97美元
  市场透视 · 2025-03-01
  Mangoceuticals, Inc.盘中异动股价大跌5.53%报3.97美元
- Mangoceuticals, Inc.盘中异动大幅下跌5.19%
  市场透视 · 2025-02-28
  Mangoceuticals, Inc.盘中异动大幅下跌5.19%
- Mangoceuticals, Inc.盘中异动股价大跌5.76%报4.34美元
  市场透视 · 2025-02-25
  Mangoceuticals, Inc.盘中异动股价大跌5.76%报4.34美元
- Mangoceuticals, Inc.盘中异动急速拉升5.31%
  市场透视 · 2025-02-25
  Mangoceuticals, Inc.盘中异动急速拉升5.31%
- Mangoceuticals, Inc.盘中异动快速跳水6.25%
  市场透视 · 2025-02-21
  Mangoceuticals, Inc.盘中异动快速跳水6.25%
- Mangoceuticals, Inc.盘中异动快速上涨5.59%报5.10美元
  市场透视 · 2025-02-19
  Mangoceuticals, Inc.盘中异动快速上涨5.59%报5.10美元
公司概况
公司名称
Mangoceuticals, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.mangorx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Mangoceuticals, Inc.于2021年10月7日在德克萨斯州成立，旨在通过远程医疗平台开发、营销和销售各种男性健康产品和服务。迄今为止，该公司已将男性健康远程医疗服务和产品确定为近年来增长的行业，尤其是与勃起功能障碍相关的领域。在这方面，Mangoceuticals目前正在开发并准备通过FDA批准的成分的专有组合销售一种新品牌的勃起功能障碍（ED）产品。
- 02-20 05:05
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-06
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-23
  [修订]招股说明书
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 01-13
  招股说明书
  Form S-1 - General form for registration of securities under the Securities Act of 1933
  Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-12-19
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-12-19
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-12-10
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-12-03
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-19
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-14
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-14
  [修订]季度报告
  Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
  Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
- 2025-11-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-11-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-10-29
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-09-12
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report

分时
5日
日
周
月

数据加载中...

最高

0.6890

今开

0.6235

量比

202.91

最低

0.4782

昨收

0.3561

换手率

2782.36%

Mangoceuticals, Inc.(MGRX)

公司概况

热议股票